US, EMEA, Mexico & Brazil Molecular Diagnostics Market Volume Data 2010 - 2014

This product provides the volume of molecular diagnostic testing for historic and forecast years covering the following markets: United Staes, EMEA, Mexico and Brazil. Please note that this product is only to be purchased in conjunction with the report titled "Global Molecular Diagnostics Market & Future Forecast 2010 - 2014".

Molecular diagnostics is a vital and dynamic field in which yesterdays new technologies and platforms are today becoming populated with novel, diverse, and useful content. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 15 Billion by 2014.The fastest growing segment is infectious disease with 21% market share as the dominant segment. The next fastest growing segment is oncology testing due to rising cases of cancer patients .The future growth is expected to come from genetic testing, blood screening testing and neurological testing.

Geographically, the US and EMEA markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However, Japanese molecular diagnostics market is promising with the ageing population and a declining birth rate is putting the whole Japanese healthcare system under pressure. Under such circumstances, the role of preventive medical care is increasingly important. China and India molecular diagnostics market is one of the lucrative markets to rollout the diagnosis business.